448 related articles for article (PubMed ID: 31262807)
1. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS.
Leyton-Jaimes MF; Kahn J; Israelson A
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14755-14760. PubMed ID: 31262807
[TBL] [Abstract][Full Text] [Related]
2. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.
Leyton-Jaimes MF; Benaim C; Abu-Hamad S; Kahn J; Guetta A; Bucala R; Israelson A
Proc Natl Acad Sci U S A; 2016 Sep; 113(36):10198-203. PubMed ID: 27551074
[TBL] [Abstract][Full Text] [Related]
3. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.
Israelson A; Ditsworth D; Sun S; Song S; Liang J; Hruska-Plochan M; McAlonis-Downes M; Abu-Hamad S; Zoltsman G; Shani T; Maldonado M; Bui A; Navarro M; Zhou H; Marsala M; Kaspar BK; Da Cruz S; Cleveland DW
Neuron; 2015 Apr; 86(1):218-32. PubMed ID: 25801706
[TBL] [Abstract][Full Text] [Related]
5. MIF homolog d-dopachrome tautomerase (D-DT/MIF-2) does not inhibit accumulation and toxicity of misfolded SOD1.
Alaskarov A; Barel S; Bakavayev S; Kahn J; Israelson A
Sci Rep; 2022 Jun; 12(1):9570. PubMed ID: 35688953
[TBL] [Abstract][Full Text] [Related]
6. MIF inhibits the formation and toxicity of misfolded SOD1 amyloid aggregates: implications for familial ALS.
Shvil N; Banerjee V; Zoltsman G; Shani T; Kahn J; Abu-Hamad S; Papo N; Engel S; Bernhagen J; Israelson A
Cell Death Dis; 2018 Jan; 9(2):107. PubMed ID: 29371591
[TBL] [Abstract][Full Text] [Related]
7. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
Tokuda E; Nomura T; Ohara S; Watanabe S; Yamanaka K; Morisaki Y; Misawa H; Furukawa Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2119-2130. PubMed ID: 29551730
[TBL] [Abstract][Full Text] [Related]
8. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of MIF on accumulation of canine degenerative myelopathy-associated mutant SOD1 aggregation.
Nomura S; Kobatake Y; Takashima S; Kamishina H; Urushitani M; Nishii N
Res Vet Sci; 2022 Oct; 147():7-11. PubMed ID: 35364344
[TBL] [Abstract][Full Text] [Related]
10. Early upregulation of cytosolic phospholipase A
Malada Edelstein YF; Solomonov Y; Hadad N; Alfahel L; Israelson A; Levy R
J Neuroinflammation; 2021 Nov; 18(1):274. PubMed ID: 34823547
[TBL] [Abstract][Full Text] [Related]
11. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
Patel P; Kriz J; Gravel M; Soucy G; Bareil C; Gravel C; Julien JP
Mol Ther; 2014 Mar; 22(3):498-510. PubMed ID: 24394188
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor as a component of selective vulnerability of motor neurons in ALS.
Abu-Hamad S; Israelson A
Rare Dis; 2015; 3(1):e1061164. PubMed ID: 26459694
[TBL] [Abstract][Full Text] [Related]
15. Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice.
Zetterström P; Graffmo KS; Andersen PM; Brännström T; Marklund SL
J Biol Chem; 2011 Jun; 286(23):20130-6. PubMed ID: 21493711
[TBL] [Abstract][Full Text] [Related]
16. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS.
Ayers JI; Diamond J; Sari A; Fromholt S; Galaleldeen A; Ostrow LW; Glass JD; Hart PJ; Borchelt DR
Acta Neuropathol; 2016 Dec; 132(6):827-840. PubMed ID: 27704280
[TBL] [Abstract][Full Text] [Related]
17. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.
Biferi MG; Cohen-Tannoudji M; Cappelletto A; Giroux B; Roda M; Astord S; Marais T; Bos C; Voit T; Ferry A; Barkats M
Mol Ther; 2017 Sep; 25(9):2038-2052. PubMed ID: 28663100
[TBL] [Abstract][Full Text] [Related]
18. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis.
Medinas DB; Rozas P; Martínez Traub F; Woehlbier U; Brown RH; Bosco DA; Hetz C
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8209-8214. PubMed ID: 30038021
[TBL] [Abstract][Full Text] [Related]
20. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
